Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Espinel-Ingroff

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|September 15, 2004
Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus sppCarmen Castro, M Carmen Serrano, Bernardo Flores, et al.
Journal of Clinical Microbiology|July 3, 2009
Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeastsAna Espinel-Ingroff, E Canton, J Peman, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometryCidália Pina-Vaz, Sofia Costa-de-Oliveira, Acácio G Rodrigues, et al.
Diagnostic Microbiology and Infectious Disease|August 12, 2008
Comparison of posaconazole and voriconazole in vitro killing against Candida kruseiEmilia Cantón, Javier Pemán, Amparo Valentín, et al.
Diagnostic Microbiology and Infectious Disease|March 29, 2003
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida speciesEmilia Cantón, Javier Pemán, Angel Viudes, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
<i>In Vitro</i> Activity of Fenticonazole against <i>Candida</i> and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing AssaysMaurizio Sanguinetti, Emilia Cantón, Riccardo Torelli, et al.
Revista Iberoamericana De Micologia|March 15, 2008
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibilityElena Eraso, Maite Ruesga, María Villar-Vidal, et al.
The Journal of Antimicrobial Chemotherapy|November 24, 2007
Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeastsEmilia Cantón, Javier Pemán, Ana Espinel-Ingroff, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2002
Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution methodMaría Pilar Arévalo, Alfonso-Javier Carrillo-Muñoz, Javier Salgado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2007
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosisFlavio Queiroz-Telles, Luciano Z Goldani, Haran T Schlamm, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|September 15, 2004
Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus sppCarmen Castro, M Carmen Serrano, Bernardo Flores, et al.
Journal of Clinical Microbiology|July 3, 2009
Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and other yeastsAna Espinel-Ingroff, E Canton, J Peman, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometryCidália Pina-Vaz, Sofia Costa-de-Oliveira, Acácio G Rodrigues, et al.
Diagnostic Microbiology and Infectious Disease|August 12, 2008
Comparison of posaconazole and voriconazole in vitro killing against Candida kruseiEmilia Cantón, Javier Pemán, Amparo Valentín, et al.
Diagnostic Microbiology and Infectious Disease|March 29, 2003
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida speciesEmilia Cantón, Javier Pemán, Angel Viudes, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
<i>In Vitro</i> Activity of Fenticonazole against <i>Candida</i> and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing AssaysMaurizio Sanguinetti, Emilia Cantón, Riccardo Torelli, et al.
Revista Iberoamericana De Micologia|March 15, 2008
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibilityElena Eraso, Maite Ruesga, María Villar-Vidal, et al.
The Journal of Antimicrobial Chemotherapy|November 24, 2007
Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeastsEmilia Cantón, Javier Pemán, Ana Espinel-Ingroff, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2002
Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution methodMaría Pilar Arévalo, Alfonso-Javier Carrillo-Muñoz, Javier Salgado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2007
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosisFlavio Queiroz-Telles, Luciano Z Goldani, Haran T Schlamm, et al.
Pageof 5